Unlock Global Insights – Save 20% on Market Reports with Code ONLINE20
By How Much Is The Therapeutic Plasma Exchange Market Expected To Expand Between 2025 And 2029?
The therapeutic plasma exchange market size has experienced strong growth in recent years. It is projected to expand from $1.47 billion in 2024 to $1.61 billion in 2025, achieving a compound annual growth rate (CAGR) of 9.5%. The expansion witnessed during the historic period can be attributed to the proliferation of immunological diseases, continuous technological advancements, greater awareness and educational initiatives, an increase in recognized indications, and a more thorough understanding of pathophysiology.
The market size for therapeutic plasma exchange is projected to experience robust expansion over the coming years. By 2029, it is anticipated to reach $2.25 billion, expanding at a compound annual growth rate (CAGR) of 8.7%. This expansion during the forecast period is attributable to factors such as the increasing geriatric population, supportive clinical evidence and guidelines, a favorable regulatory environment, enhancements in hospital infrastructure and healthcare investments, growing healthcare expenditure, and effective reimbursement policies. Key developments foreseen in this period encompass personalized therapies, the incorporation of automation, various collaborative initiatives, and the integration of telemedicine.
Unlock Your Free Sample Report for Exclusive Market Data:
https://www.thebusinessresearchcompany.com/sample.aspx?id=15683&type=smp
Which Drivers Are Shaping The Therapeutic Plasma Exchange Industry’s Market Share?
The significant occurrence of hematological disorders is anticipated to fuel the expansion of the therapeutic plasma exchange market in the future. These conditions, also known as blood disorders, are medical ailments impacting the blood and related tissues like bone marrow, lymph nodes, and the spleen. The incidence of hematological disorders is increasing due to various elements such as genetic factors, environmental influences, and evolving lifestyle habits. Therapeutic plasma exchange (TPE) is employed in treating hematological disorders to extract disease-causing agents from plasma, for example, autoantibodies in autoimmune hemolytic anemia or immune complexes in thrombotic thrombocytopenic purpura, which helps lessen disease severity and enhance patient recovery. As an illustration, the Leukemia and Lymphoma Society, a US-based professional body, reported in August 2023 that the anticipated diagnoses of myeloma are predicted to increase by approximately 2.3% from 2021 to 2023, rising from 34,920 to 35,730. Consequently, the widespread occurrence of hematological disorders serves as a key impetus for the expansion of the therapeutic plasma exchange market.
What Are The Major Segment Categories Driving The Therapeutic Plasma Exchange Market Growth?
The therapeutic plasma exchangemarket covered in this report is segmented –
1) By Type: Therapeutic Plasma Exchange (TPE); Double Filtered Plasmapheresis (DFPP)
2) By Indication: Neurological Disorders; Hematological Disorders; Renal Disorders; Metabolic Disorders; Other Indications
3) By Technology: Centrifugation; Membrane Separation
4) By End User: Blood Collection Centers; Hospitals And Clinics; Transfusion Centers; Other End Users
Subsegments:
1) By Therapeutic Plasma Exchange (Tpe): Manual Tpe; Automated Tpe
2) By Double Filtered Plasmapheresis (Dfpp): Single-Stage Dfpp; Multi-Stage Dfpp
Which Trends Are Impacting The Therapeutic Plasma Exchange Market?
Leading companies in the therapeutic plasma exchange market are adopting strategic partnerships to improve technology integration and broaden their market presence. A strategic partnership typically describes a collaborative relationship between two or more organizations that combine their resources, expertise, and efforts to achieve shared goals or objectives. For example, in July 2022, Terumo Blood and Cell Technologies, a US-based technology company, partnered with Eliaz Therapeutics Inc., a US-based medical device company specializing in therapeutic apheresis for inflammatory and kidney-related conditions, to address acute kidney injury (AKI) and sepsis-induced AKI (S-AKI) by selectively removing the inflammatory protein Gal-3 from blood plasma. Given the high mortality rates associated with AKI, the collaboration aims to explore novel treatments using Terumo’s Spectra Optia Apheresis System and ETI’s XGal-3 column. Initial studies will concentrate on large animals before advancing to human clinical trials. Terumo, recognized for its innovation in therapeutic apheresis, has previously collaborated on projects targeting conditions such as triple-negative breast cancer and COVID-19.
Who Are The Primary Competitors In The Global Therapeutic Plasma Exchange Market?
Major companies operating in the therapeutic plasma exchange market are Medica S.p.A., Fresenius SE and Co. KGaA, Medtronic Plc., Asahi Kasei Corporation, Toray Industries Inc., Baxter International Inc., B Braun Melsungen AG, Terumo Corporation, Kaneka Corporation, Charles River Laboratories, Octapharma AG, Spectral Medical Inc., Nikkiso Co. Ltd., Haemonetics Corporation, Miltenyi Biotec Technology And Trading Co. Ltd., Macopharma SA, Cerus Corporation, Apellis Pharmaceuticals Inc., ImmunoTek Bio Centers LLC, CytoSorbents Corporation, Kawasumi Laboratories America Inc., Japan Medical Supply Co. Ltd.
Download The Full Report For Exclusive Market Findings:
https://www.thebusinessresearchcompany.com/report/therapeutic-plasma-exchange-global-market-report
What Are The Regional Market Dynamics Impacting The Therapeutic Plasma Exchange Industry?
North America was the largest region in the therapeutic plasma exchange market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the therapeutic plasma exchange market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Request A Customized Version Of The Therapeutic Plasma Exchange Market Report:
https://www.thebusinessresearchcompany.com/customise?id=15683&type=smp
Browse Through More Reports Similar to the Global Therapeutic Plasma Exchange Market 2025, By The Business Research Company
Neurodegenerative Disorder Therapeutic Global Market Report 2025
Respiratory Devices And Equipment Therapeutic Global Market Report 2025
Antisense And Rnai Therapeutics Global Market Report 2025
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model